Abstract
AbstractIntroductionImproving care coordination for people with rare conditions may help to reduce burden on patients and carers and improve the care that patients receive. We recently developed a taxonomy of different ways of coordinating care for rare conditions. It is not yet known which models of care coordination are appropriate in different situations. This study aimed to: i) explore what types of care coordination may be appropriate in different situations, and ii) use these findings to develop hypothetical models of care coordination for rare conditions.MethodsTo explore appropriateness of different types of care coordination, we conducted interviews (n=30), four focus groups (n=22) and two workshops (n=27) with patients, carers, healthcare professionals, commissioners, and charity representatives. Participants were asked about preferences, benefits and challenges, and the factors influencing coordination. Thematic analysis was used to develop hypothetical models of care coordination. Models were refined following feedback from workshop participants.ResultsStakeholders prefer models of care that: are nationally centralised or a hybrid of national and local care, involve professionals collaborating to deliver care, have clear roles and responsibilities outlined (including administrative, coordinator, clinical and charity roles), provide access to records and offer flexible appointments (in terms of timing and mode). Many factors influenced coordination, including those relating to the patient (e.g., condition complexity, patient’s location and ability to coordinate their own care), the healthcare professional (e.g., knowledge and time), the healthcare environment (e.g., resources) and societal factors (e.g., availability of funding). We developed and refined ten illustrative hypothetical models of care coordination for rare conditions.ConclusionFindings underline that different models of care coordination may be appropriate in different situations. It is possible to develop models of care coordination which are tailored to the individual in context. Findings may be used to facilitate planning around which models of care coordination may be appropriate in different services or circumstances. Findings may also be used by key stakeholders (e.g. patient organisations, clinicians and service planners) as a decision-making tool.
Publisher
Cold Spring Harbor Laboratory
Reference33 articles.
1. Rethinking the patient: using Burden of Treatment Theory to understand the changing dynamics of illness;BMC health services research,2014 1
2. Department of Health, Northern Ireland Executive, Scottish Government, The National Assembly for Wales. The UK Strategy for Rare Diseases. Department of Health, 2013. https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/260562/UK_Strategy_for_Rare_Diseases.pdf
3. Rare Disease UK. Understanding children and young people’s experiences. 2018. Accessed from: http://www.raredisease.org.uk/media/3348/understanding-children-and-young-peoples-experiences-website.pdf
4. Why rare diseases are an important medical and social issue;The Lancet,2008
5. The All Party Parliamentary Group (APPG) on Rare, Genetic and Undiagnosed Conditions. Leaving no one behind: why England needs an implementation plan for the UK Strategy for Rare Diseases. RDUK, 2017.https://www.raredisease.org.uk/media/2757/final-for-website.pdf